Name: GPS (Genomic Prostate Score)
Brand: Confirm mdx

Health and Medical

Confirm mdx is a genomic assay designed for men with low-, intermediate-, and high-risk localized prostate cancer to help guide treatment decisions. It addresses prostate biopsy sampling error and the false-negative biopsy dilemma, improving patient stratification and risk assessment.  The test is supported by Level 1 Evidence and can be used with at-home collection.

Confirm mdx

Science and Engineering

Biotechnology

California

Biopharma

Life Science

The GPS test is a genomic assay designed for men with low-, intermediate-, and high-risk localized prostate cancer to help guide treatment decisions. It is a tissue-based test that helps identify patients for active surveillance or intervention. GPS is supported by Level 1 Evidence.

GPS (Genomic Prostate Score)

Other products/services from Confirm mdx

Confirm mdx

N/A